TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony ℠, a leader in holistic stress relief, proudly ...

The new add-on aims to streamline laboratory labeling by combining the Dymo® LabelWriter™5-Series (550, 550 Turbo, and 5XL) ...

Value of Veterinarians: Veterinarians continue to be the most trusted source of information about pet health for pet owners, with the majority of Canadians surveyed valuing their expertise, ...

The best bulking cycles combine anabolic steroids that promote muscle growth, strength, and recovery. A popular beginner ...

This investment is pending the closing of the merger between SRx Health Solutions and Better Choice Company, which is scheduled for late-April. Upon closing, the combined companies will emerge as a ...

Each Unit consisted of (i) one common share in the capital of the Company (each, a “ Common Share ”), and (ii) one Common Share purchase warrant (each, a “ Warrant ”). Each Warrant entitles the holder ...

The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at Tr1X, with patients enrolling at leading stem cell transplant centers across ...

Radforsk Investeringsstiftelse, a close associate of Anders Tuv, Chair of the board of directors and primary insider of the Company, has today transferred 1730 existing shares in the Company to DNB ...

Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin ...

Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. (“POI”) dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 ...

OPKO currently expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The Company had approximately 671.6 million shares outstanding as of February 24, ...

Long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset seizures (FOS) ...